Kaplan-Meier estimated durations of MRD negativity during treatment with oral azacitidine and placebo, regardless of MRD status at baseline. Duration of “0” on the x-axis represents patients who never achieved protocol-defined MRD⁻ status on study. Patients with missing or insufficient longitudinal data are not included in this analysis.